Core Insights - The article emphasizes the need for a more efficient pricing and resource allocation system in China's capital market, highlighting the challenges posed by a fragmented investor base and the lack of a widely accepted fundamental evaluation system [3] Group 1: Investment Philosophy - Regulatory bodies have been advocating for rational, value, and long-term investment philosophies to promote high-quality development in the capital market [3] - The article questions whether AI technology can help create an independent, objective, and quantitative fundamental evaluation system that enhances market efficiency [3] Group 2: AI and Investment Research - The potential of AI in investment research is discussed, particularly its ability to empower various stakeholders in the investment ecosystem, including buy-side, sell-side, and service providers [3] - The article raises questions about the type of investment advisory services that individual investors will need in the AI era [3] Group 3: Forum Agenda - The agenda for the upcoming forum includes discussions on the release of the "2025 Ranking" for Chinese listed companies with the strongest economic moats and the role of intelligent investment research in improving decision-making efficiency [4][5] - Keynote speeches will address the reliability of brokerage research earnings forecasts and the challenges and opportunities presented by large models in investment research [4][5]

Core Viewpoint - The upcoming investment research conference on July 11 will introduce the "One Rating" series, a new professional stock evaluation system by Yicai, providing investors with a fresh reference dimension [2]. Group 1 - The event will be live-streamed from 18:10 to 19:20, featuring various investment research experts analyzing market trends and investment directions [3][7]. - The conference will focus on current investment hotspots and discuss several key topics, including the balance between change and stability in investments, the dynamics of old and new consumer markets, and the future of high-dividend stocks [8][9]. - Specific discussions will include the rapid rise of Chinese innovative pharmaceuticals and the core driving forces behind this trend, as well as opportunities in technology stocks [9].